At that time, AFBG was chosen as the treatment of choice because of our patient’s low ventricular ejection fraction (35%) in addition to several comorbidities, including diabetes (type 2 diabetes mellitus treated with insulin) and high blood pressure (for which he was being treated), and his long history of tobacco use (active smoker for about 40 years). Here, INS is linked to diabetes mellitus.